Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders

about

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders

Item

http://www.wikidata.org/entity/Q59128393

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Hematopoietic Stem Cell Transp ...... eases and Associated Disorders

@en

Hematopoietic Stem Cell Transp ...... eases and Associated Disorders

@nl

type

Item

label

Hematopoietic Stem Cell Transp ...... eases and Associated Disorders

@en

Hematopoietic Stem Cell Transp ...... eases and Associated Disorders

@nl

prefLabel

Hematopoietic Stem Cell Transp ...... eases and Associated Disorders

@en

Hematopoietic Stem Cell Transp ...... eases and Associated Disorders

@nl

P1476

Hematopoietic Stem Cell Transp ...... eases and Associated Disorders

@en

P2093

Akihisa Sawada

http://www.w3.org/2001/XMLSchema#string

Masami Inoue

http://www.w3.org/2001/XMLSchema#string

P2860

How we treat chronic active Epstein-Barr virus infection.

[Temporary effective treatment with L-asparaginase for a patient with refractory nasal NK/T-cell lymphoma].

Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells.

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.

Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection.

P304

334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPED.2018.00334

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30460216

http://www.w3.org/2001/XMLSchema#string

P932

6232123

http://www.w3.org/2001/XMLSchema#string